Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-23
2011-08-23
Andres, Janet L. (Department: 1622)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S511000
Reexamination Certificate
active
08003812
ABSTRACT:
A taxane having a cyclopentyl ester substituent at C10, a keto substituent at C9, a hydroxy substituent at C2, a 2-thienyl substituent at C3′ and an isopropoxycarbamate substituent at C3′.
REFERENCES:
patent: 4814470 (1989-03-01), Colin et al.
patent: 5175315 (1992-12-01), Holton
patent: 5200534 (1993-04-01), Rao
patent: 5227400 (1993-07-01), Holton et al.
patent: 5243045 (1993-09-01), Holton et al.
patent: 5250683 (1993-10-01), Holton et al.
patent: 5254580 (1993-10-01), Chen et al.
patent: 5274124 (1993-12-01), Holton
patent: 5283253 (1994-02-01), Holton et al.
patent: 5350866 (1994-09-01), Holton et al.
patent: 5367086 (1994-11-01), Rao
patent: 5407674 (1995-04-01), Gabetta et al.
patent: 5430160 (1995-07-01), Holton
patent: 5475011 (1995-12-01), Ojima et al.
patent: 5556878 (1996-09-01), Kelley et al.
patent: 5567614 (1996-10-01), Patel et al.
patent: 5614645 (1997-03-01), Kingston et al.
patent: 5714512 (1998-02-01), Bastart et al.
patent: 5714513 (1998-02-01), Holton et al.
patent: 5721268 (1998-02-01), Holton et al.
patent: 5739362 (1998-04-01), Holton et al.
patent: 5756776 (1998-05-01), Bombardelli et al.
patent: 5767297 (1998-06-01), Mandai et al.
patent: 5780653 (1998-07-01), Tao et al.
patent: 5811452 (1998-09-01), Ojima et al.
patent: 5879929 (1999-03-01), Patel
patent: 5889043 (1999-03-01), Bouchard et al.
patent: 5906990 (1999-05-01), Bouchard et al.
patent: 5912264 (1999-06-01), Wittman et al.
patent: 5959125 (1999-09-01), Bouchard et al.
patent: 5965739 (1999-10-01), Kelly et al.
patent: 6025385 (2000-02-01), Shimizu et al.
patent: 6136808 (2000-10-01), Abe et al.
patent: 6156789 (2000-12-01), Bissery et al.
patent: 6268381 (2001-07-01), Shimizu et al.
patent: 6369244 (2002-04-01), Holton et al.
patent: 6638973 (2003-10-01), Holton
patent: 6649632 (2003-11-01), Holton
patent: 6660866 (2003-12-01), Holton
patent: 6780879 (2004-08-01), Holton
patent: 2001/0002404 (2001-05-01), Webb et al.
patent: 0 534 709 (1993-03-01), None
patent: 0 558 959 (1993-09-01), None
patent: 0 590 267 (1994-04-01), None
patent: 0 590 267 (1994-04-01), None
patent: 0 600 517 (1994-06-01), None
patent: 0 604 910 (1994-07-01), None
patent: 0 629 701 (1994-12-01), None
patent: 0 639 577 (1995-02-01), None
patent: 0 882 732 (1998-12-01), None
patent: 93/06079 (1993-04-01), None
patent: 93/18018 (1993-09-01), None
patent: 93/23389 (1993-11-01), None
patent: 94/07880 (1994-04-01), None
patent: 94/13655 (1994-06-01), None
patent: 94/20484 (1994-09-01), None
patent: 95/04154 (1995-02-01), None
patent: 96/13495 (1996-05-01), None
patent: 96/30356 (1996-10-01), None
patent: 97/07110 (1997-02-01), None
patent: 97/09979 (1997-03-01), None
patent: 97/32578 (1997-09-01), None
patent: 97/42181 (1997-11-01), None
patent: 97/44026 (1997-11-01), None
patent: 97/44063 (1997-11-01), None
patent: 98/02426 (1998-01-01), None
patent: 99/09021 (1999-02-01), None
patent: 99/14209 (1999-03-01), None
patent: 99/32473 (1999-07-01), None
patent: 00/53592 (2000-09-01), None
patent: 01/57013 (2001-08-01), None
patent: 01/57032 (2001-08-01), None
patent: 01/68089 (2001-09-01), None
patent: 2006/088767 (2006-08-01), None
patent: 96/14308 (2009-09-01), None
Alley et al, Human Tumor Xenograft Models in NCI Drug Development, Anticancer Drug Development Guide, pp. 125-152 (Humana Press, Totowa, NJ, 2004).
Appendino et al. “Synthesis of Paclitaxel (Docetaxel) / 2-Deacetoxytaxinine J Dimers” Tetrahedron, vol. 55 (1999) pp. 6567-6576.
Burger et al., Screening Using Animal Systems, Anticancer Drug Development, pp. 285-299 (Academic Press, San Diego, CA, 2002).
Cravallee et al. “Methyleniminium Salts as Acylating Agent—One Step Synthesis of Baccatin III from 10-Deacetylbaccatin III with High Selectivity” Tetrahedron Letters, vol. 39 (1998) pp. 4263-4266.
Dubois et al. “Fluorescent and Biotinylated Analogues of Docetaxel: Synthesis and Biological Evaluation” Bioorganic & Medicinal Chemistry, vol. 3, No. 10 (1995) pp. 1357-1368.
Fiebig et al., Human Tumor Xenografts and Explants, Tumor Models in Cancer Research 113-137 (Humana Press, Totowa, NJ, 2002).
Guenard et al. “Effects of the Hydrophobicity of Taxoids on Their Interaction with Tubulin” Bioorganic & Medicinal Chemistry, vol. 8 (2000) pp. 145-156.
Gueritte-Voegelein et al. “Relationships between the Structure of Taxol Analogues and Their Antimitotic Activity” Journal of Medicinal Chemistry, vol. 34, No. 3 (1991) pp. 992-998.
Ishihara et al. “Scandium Trifluoromethanesulfonate as an Extremely Active Acylation Catalyst” J. Am. Chem. Soc., vol. 117, No. 15 (1995) pp. 4413-4414.
Journal of Chinese Universities, vol. 21:3, (2000), pp. 401-406.
Journal of Tianjin University, vol. 33:1, (200), pp. 51-55.
Kant et al. “A Chemoselective Approach to Functionalize the C-10 Position of 10-Deacetylbaccatin III. Synthesis and Biological Properties of Novel C-10 Taxol Analogues” Tetrahedron Letters, vol. 35, No. 30 (1994) pp. 5543-5546.
Kingston et al., Bioactivity of Taxol and Other Taxoids, Progress in the Chemistry of Organic Natural Products 160-165 (Springer-Verlag, New York, 1993).
Kirikae et al. “Structural Significance of the Acyl Group at the C-10 Position and the A Ring of the Taxane Core of Paclitaxel for Inducing Nitric Oxide and Tumor Necrosis Factor Production by Murine Macrophages” FEBS Letters, vol. 478 (2000) pp. 221-226.
Kirikae et al. “Structural Requirements of Taxoids for Nitric Oxide and Tumor Necrosis Factor Production by Murine Macrophages” Biochemical and Biophysical Research Communications, vol. 227 (1996) pp. 227-235 (Article No. 1494).
Kobayashi et al. “Modulation of Multidrug Resistance by Taxuspine C and Other Taxoids from Japanese Yew” Bioorganic & Medicinal Chemistry Letters, vol. 8 (1998) pp. 1555-1558.
Lin et al. “Synthesis of Highly Potent Second-Generation Taxoids Through Effective Kinetic Resolution Coupling of Racemic β-Lactams with Baccatins” Chirality, vol. 12, No. 5/6 (2000) pp. 431-441.
Longley et al., In Vivo Efficacy of TL-310, Presented at 97th Annual Meeting of American Association for Cancer Research on Apr. 1-5, 2006.
Longley et al., In vitro mechanism of action studies with the taxane analog, TL-909 (MST-997), Abstract Presented at the 95th Annual Meeting of the American Association for Cancer Research, Orlando, FL, Mar. 27-31, 2004.
Longley et al., In vitro mechanism of action studies with the taxane analog, TL-310, Abstract Presented at the 96th Annual Meeting of the American Association for Cancer Research, Anaheim, CA, Apr. 16-20, 2005.
McFadyen, et al., “Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance” Biochemical Pharmacology 62 (2001) 207-212.
Ojima et al. “Synthesis and Structure—Activity Relationships of the Second-Generation Antitumor Taxoids: Exceptional Activity Against Drug-Resistant Cancer Cells” J. Med. Chem., vol. 39, No. 20 (1996) pp. 3889-3896.
Ojima et al. “Synthesis and Biological Activity of Novel 3′-Trifluoromethyl Taxoids” Bioorganic & Medicinal Chemistry, vol. 7, No. 2 (1997) pp. 133-138.
Ojima et al. “Synthesis of Novel 3′-Trifluoromethyl Taxoids Through Effective Kinetic Resolution of Racemic 4-CF3-β-Lactams With Baccatins” Chirality, vol. 9 (1997) pp. 487-494.
Ojima et al. “Efficient Asymmetric Synthesis of β-Lactams Bearing A Cyclopropane or an Epoxide Moiety and Their Application to the Synthesis of Novel Isoserines and Taxoids” Journal of Organic Chemistry, vol. 63, No. 2 (1998) pp. 224-225.
Ojima et al. “New Photoaffinity Analogs of Paclitaxel” Bioorganic & Medicinal Chemistry Letters, vol. 9 (1999) pp. 1189-1194.
Ojima et al. “Enantiopure Fluorine-Containing Taxoids: Potent Anticancer Agents and Versatile Probes for Biomedical Problems” Journal of Fluorine Chemistry, vol. 97 (1999) pp. 3-10.
Ojima et al. Synthesis and Structure-Activity
Holton Robert A.
Vu Phong
Andres Janet L.
Cave LLP Bryan
Covington Raymond
Florida State University Research Foundation, Inc.
LandOfFree
C10 cyclopentyl ester substituted taxanes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with C10 cyclopentyl ester substituted taxanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C10 cyclopentyl ester substituted taxanes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2689658